A one-hour talk could change how latino men decide on prostate cancer screening
NCT ID NCT00761124
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This trial tests whether a one-hour group discussion helps Latino men aged 50 to 70 make informed decisions about PSA screening for prostate cancer. Participants receive either a printed pamphlet or an interactive session covering the benefits, risks, and controversy around PSA testing. Researchers then measure knowledge, communication with family and doctors, and whether men actually get screened. The goal is to see if education can support better decision-making in this group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A one-hour interactive group discussion led by a facilitator, plus a printed prostate cancer pamphlet
- What this could lead to
- If it works, this approach could help Latino men make better-informed decisions about prostate cancer screening, potentially reducing unnecessary tests while catching real cases earlier.
- What could go wrong
- The trial is early and measures knowledge and screening rates, not long-term health outcomes. The discussion may not change decisions or may not work outside this specific group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,006 people
The number who actually took part.
- Started
-
Apr 2003
- Finished
-
Apr 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 70 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Latino men * 50 to 70 years old * Not ever having prostate biopsy * Not ever having prostate cancer * Not having had a PSA test within the past 12 months * Not having BPH (prostate inflammation) * Not currently experiencing prostate problems such as pain or burning sensation during urination, blood in urine, and/or desire to urinate frequently Exclusion Criteria: * Not Latino * Younger than 50 or older than 70 years old * Currently experiencing prostate problems such as pain or burning sensations while urinating, blood in urine, and/or desire to urinate frequently * Living outside of Los Angeles county * Having had a prostate biopsy * Having had prostate cancer previously * Having had a prostatectomy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA, Division of Cancer Prevention and Control Research
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- RE-irradiation for isolated FOCal recurrence of prostate cancer with ultrahypofracted SBRT: the RE-FOCUS study - pushing the boundaries of precision and efficacy
- A sharper eye for cancer: new PET tracer targets hidden tumors
- Can a radioactive tracer help surgeons find hidden prostate cancer?
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Can smart fluid monitoring improve robotic prostatectomy outcomes?
- Smart blood pressure monitoring may shield kidneys during robotic surgery